For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Sirnaomics, Inc.

USPTO Granted Patents = 12

% Expired Patents = 16.7

EPO Patents = 2

Trademarks = 2

Forward Citations = 24

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Patrick Y Lu (10 out of 21 patents)

John Xu (6 out of 6 patents)

Vera Simonenko (5 out of 6 patents)

4. David R Evans (4 out of 109 patents)

5. David M Evans (3 out of 3 patents)

6. Alan Y Lu (2 out of 2 patents)

7. Xiaoyong Lu (2 out of 2 patents)

8. Dmitry Samarsky (2 out of 2 patents)

9. Qingfeng Li (1 out of 6 patents)

10. Yibin Cai (1 out of 1 patent)

11. Qing Ge (1 out of 1 patent)

12. Bojian Zheng (1 out of 6 patents)

13. Qingquan Tang (1 out of 1 patent)

14. Martin Woodle (1 out of 7 patents)

15. Jia Zhou (1 out of 1 patent)

12 patents: Sort by Forward Citations

1. 12685775 - OLIGONUCLEOTIDES WITH NUCLEOSIDE ANALOGS (2026-07-21),

2. 12600967 - SiRNA compound that inhibits complement factor B (CFB) (2026-04-14),

3. 12378552 - Oligomeric compound for inhibiting expression of factor XI (2025-08-05),

4. 12054714 - Peptide docking vehicle for targeted nucleic acid delivery (2024-08-06),

5. 12006500 - Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV) (2024-06-11),

6. 11697813 - Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis (2023-07-11),

7. 11058779 - Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection (2021-07-13),

8. RE46873 - Multi-targeted RNAi therapeutics for scarless wound healing of skin (2018-05-28),

9. 9868952 - Compositions and methods for 'resistance-proof' SiRNA therapeutics for influenza (2018-01-16),

10. 9642873 - Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application (2017-05-09),

11. 9506063 - SiRNA compositions and methods for treatment of HPV and other infections (2016-11-29),

12. 8691781 - Compositions for treating respiratory viral infections and their use (2014-04-08),

Sirnaomics, Inc. is a leading clinical-stage biopharmaceutical company in the field of RNAi therapeutics. The company focuses on the discovery and development of innovative RNAi-based therapeutics for the treatment of various diseases, including cancer and fibrotic diseases. With a strong pipeline of potential therapies and a commitment to advancing precision medicine, Sirnaomics is poised to make a significant impact in the healthcare industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

12 Patents

#40 in Gaithersburg, MD

#350 in Maryland

#25,496 in US

#48,036 in the World

Gaithersburg, MD, United States of America

Sirnaomics, Inc.

Forward Citations = 24

21 inventors:

Patrick Y Lu (10 out of 21 patents)

John Xu (6 out of 6 patents)

Vera Simonenko (5 out of 6 patents)

4. David R Evans (4 out of 109 patents)

5. David M Evans (3 out of 3 patents)

Please report any incorrect information to [email protected]

Loading…